News Center

Many products and dosage forms received GMP re-certification


August 8, 2018, Kawin Technology's Recombinant Human Interferon α2b Vaginal Effervescent Tablets, Peginterferon α-2 Injection, Recombinant Human Interferon α2b Injection, Lyophilized Powder for Injection, Small Volume Parenteral Solutions, received Certificate of GMP for Pharmaceutical Products in China.

Dr. Zhou Desheng, Chairman of Kawin Technology, Interviewed by Beijing 赛波唯® (Sofosbuvir Tablets) Approved for HCV Treatment

+86 10 87120888